Linerixibat offers PBC patients fast relief from intense itching in trial
The experimental oral therapy linerixibat from GlaxoSmithKline (GSK) offers rapid and sustained relief from severe itch in adults with primary biliary cholangitis (PBC),…
Cholangitis is a liver condition characterized by inflammation in the bile ducts, most commonly caused by a bacterial infection but also may develop due to a variety of other causes.
Read moreA variety of treatments may be used to treat cholangitis, depending on the type and whether it is acute or chronic.
Read moreThe experimental oral therapy linerixibat from GlaxoSmithKline (GSK) offers rapid and sustained relief from severe itch in adults with primary biliary cholangitis (PBC),…
Nebokitug, an experimental infusion therapy being developed by Chemomab Therapeutics for primary sclerosing cholangitis (PSC), reduces the inflammatory…